Cargando…

Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer

BACKGROUND: FOLFIRINOX prolongs survival in patients with metastatic pancreatic cancer and may also benefit patients with locally advanced pancreatic cancer (LAPC). Furthermore, it may downstage a proportion of LAPC into (borderline) resectable disease, however data are lacking. This review assessed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rombouts, Steffi J., Walma, Marieke S., Vogel, Jantien A., van Rijssen, Lennart B., Wilmink, Johanna W., Mohammad, Nadia Haj, van Santvoort, Hjalmar C., Molenaar, I. Quintus, Besselink, Marc G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Gastrointestinal Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090009/ https://www.ncbi.nlm.nih.gov/pubmed/27370653 http://dx.doi.org/10.1245/s10434-016-5373-2

Ejemplares similares

FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study
por: Rombouts, SJ, et al.
Publicado: (2016)

Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer
por: Rombouts, Steffi J. E., et al.
Publicado: (2018)

Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies
por: van Veldhuisen, Eran, et al.
Publicado: (2019)

Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Janssen, Quisette P., et al.
Publicado: (2021)

ASO Author Reflections: The Need for Improvement of the 8th American Joint Committee on Cancer TNM Staging System for Resected Pancreatic Ductal Adenocarcinoma
por: Schouten, Thijs J., et al.
Publicado: (2022)

ASO Author Reflections: Nationwide Reflection of Clinical Outcomes in Elderly Patients after Resection of Pancreatic Cancer
por: Henry, Anne Claire, et al.
Publicado: (2022)

A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer
por: Chen, Kuei-Ting, et al.
Publicado: (2023)

Diagnostic performance of imaging modalities in chronic pancreatitis: a systematic review and meta-analysis
por: Issa, Y., et al.
Publicado: (2017)

Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study
por: van Veldhuisen, Eran, et al.
Publicado: (2022)

Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
por: Versteijne, Eva, et al.
Publicado: (2022)

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial
por: van Dam, J. L., et al.
Publicado: (2023)

Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study
por: van der Sijde, Fleur, et al.
Publicado: (2022)

Short- and Long-Term Outcomes of Pancreatic Cancer Resection in Elderly Patients: A Nationwide Analysis
por: Henry, Anne Claire, et al.
Publicado: (2022)

Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis
por: Gassert, Felix G., et al.
Publicado: (2021)

Three cases of pancreatic pseudocysts associated with dorsal pancreatic agenesis
por: Suh, Pae Sun, et al.
Publicado: (2018)

Comment on: Pancreatectomy With Islet-Autotransplantation As Alternative for Pancreatoduodenectomy in Patients With a High-Risk for Postoperative Pancreatic Fistula: The Jury Is Still Out
por: Stoop, Thomas F., et al.
Publicado: (2023)

Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
por: Janssen, Q. P., et al.
Publicado: (2021)

Pancreatic arteriovenous malformation mimicking pancreatic neoplasm: a systematic multimodality diagnostic approach and treatment
por: Nikolaidou, Olga, et al.
Publicado: (2018)

Spontaneous pancreatic pseudocyst – superior mesenteric vein fistula: A rare complication of chronic pancreatitis
por: Tomsan, Hanna, et al.
Publicado: (2020)

Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges
por: Yang, Feng, et al.
Publicado: (2019)

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
por: Anderegg, M. C. J., et al.
Publicado: (2017)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Mediastinal extension of a pancreatic pseudocyst
por: Omer, Adil, et al.
Publicado: (2018)

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
por: Katz, Matthew H. G., et al.
Publicado: (2010)

Comparing Survival after Resection of Pancreatic Cancer with and without Pancreatic Cysts: Nationwide Registry-Based Study
por: Gorris, Myrte, et al.
Publicado: (2022)

Complete dorsal pancreatic agenesis and unilateral renal agenesis
por: Moreira, Adriana, et al.
Publicado: (2017)

Diagnostic Accuracy of CT for Evaluating Circumferential Resection Margin Status in Resectable or Borderline Resectable Pancreatic Head Cancer: A Prospective Study Using Axially Sliced Surgical Pathologic Correlation
por: Park, Ji Hoon, et al.
Publicado: (2022)

Pancreatocolonic fistulization secondary to pancreatic adenocarcinoma presenting as unexplained halitosis
por: Manov, John, et al.
Publicado: (2017)

Atypical extensive pancreatic pseudocyst with hemorrhage in a hemodialysis patient
por: Taniguchi, Yoshinori, et al.
Publicado: (2020)

Pancreatic desmoid tumor: A rare case with radiologic–pathologic correlation
por: Dallaire, Dr. Frederic Bedard, et al.
Publicado: (2018)

Subcapsular hematoma resulting in hepatic ischemia as a complication of necrotizing pancreatitis
por: Duncan, David P., et al.
Publicado: (2020)

Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: A multicenter cohort study
por: Latenstein, Anouk E. J., et al.
Publicado: (2020)

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020)

Cost-effectiveness of preoperative biliary drainage for obstructive jaundice in pancreatic and periampullary cancer
por: Morris, Stephen, et al.
Publicado: (2015)

COVID-19-associated acute pancreatitis: a rare cause of acute abdomen
por: Mazrouei, Safaa Saeed Al, et al.
Publicado: (2020)

Ectopic Cushing syndrome caused by a pancreatic neuroendocrine tumor: A case report
por: Shayesteh, Shahab, et al.
Publicado: (2020)

Secretin-stimulated ultrasound estimation of pancreatic secretion in cystic fibrosis validated by magnetic resonance imaging
por: Engjom, Trond, et al.
Publicado: (2017)

Two rare cases of pancreatic adenosquamous carcinoma: A review of the literature with focus on radiologic findings
por: Cedeno Kelly, Karen, et al.
Publicado: (2019)

Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients
por: van der Sijde, Fleur, et al.
Publicado: (2022)

Development and validation of an ultrasound-based prediction model for differentiating between malignant and benign solid pancreatic lesions
por: Huang, Jiayan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fl0i4gnr3guml3od11lv688jon